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Introduction 
Proteins are bio-macromolecules consisting of basic 20 amino acids and have 
distinct three-dimensional folds. They are essential parts of organisms and participate in 
every process within cells. Proteins are crucial for human life, and each protein within the 
body has a specific function, such as antibodies, contractile proteins, enzymes, hormonal 
proteins, structural proteins, storage proteins and transport proteins [1]. Determining 
three-dimensional structure of a protein can help researchers discover the remarkable 
protein folding, binding site, conformation and etc, in order to understand well of protein 
interaction and aid for possible drug design.  
The research on protein structure by X-ray protein crystallography carried by Li-
Wei Hung’s research group in the Physical Bioscience Division at Lawrence Berkeley 
National Laboratory (LBNL) is focusing on protein crystallography. The research in this 
lab is in the process of from crystallizing the proteins to determining the three 
dimensional crystal structures of proteins. Most protein targets are selected from 
Mycobacterium Tuberculosis. TB (Tuberculosis) is a possible fatal infectious disease. By 
studying TB target protein can help discover antituberculer drugs, and find treatment for 
TB.  The high-throughput mode of crystallization, crystal harvesting, crystal screening 
and data collection are applied to the research pipeline (Figure 1). The X-ray diffraction 
data by protein crystals can be processed and analyzed to result in a three dimensional 
representation of electron density, producing a detailed model of protein structure.  
Rv0731c is a conserved hypothetical protein with unknown function from 
Mycobacterium Tuberculosis. This paper is going to report the crystallization process and 
brief structure information of Rv0731c. 
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Materials and Methods 
Protein material 
 Amount of 500 ul of 20.6 mg/ ml purified Rv0731c protein was received from 
LANL (Los Alamos National Laboratory). 
 
Crystallization process 
a. Random screen plates 
Two sets of five screen random plates, including Hampton I&II (Hampton 
Research crystal screen and Hampton Research crystal screen 2), Wizard I&II (Emerald 
Biosystem Wizard I random sparse matrix crystallization screen and Emerald Biosystem 
Wizard II random sparse matrix crystallization screen) , Wizard III_PegIon (Emerald 
Biosystem Wizard III random sparse matrix crystallization screen and Hampton Research 
PEG/Ion screen), EM_64 (Emerald Biosystems Precipitant Synergy primary 64 
crystallization screen)  and Membfac_CSLite (Hampton Research Membfac screen and 
Hampton Research Crystal Screen Lite), were setup for a target Rv0731c protein. Intelli-
Plate, a 96 well sitting drop vapor diffusion crystallographic plate with three droplets and 
a screen reservoir, was used for setting up random plates. A robotic device Phoenix 
(manufactured by Art Robbins Instruments) was used to setup random plates 
automatically. The droplet size was total 150nl which is mixed with 1:1 ratio of 
protein:reservoir and the reservoir volume is 50ul. The setup concentration of Rv0731c 
was 20.6 mg/ml. Random plates were stored in room temperature (22 °C). Total 12 initial 
crystal hits were found under 448 unique crystallization conditions. 
b. Database entry and labeling 
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These random plates then were entered into TBSGC (Mycobacterium 
Tuberculosis Structural Genomics Consortium) database. In the TBSGC database, all the 
information of Rv0731c, such as buffer type, original concentration, setup concentration, 
drop size and storage temperature, were recorded for an organized bookkeeping system. 
A plate ID is provided as the plate is entered into the database. The newly setup random 
plates are labeled with plate name and plate ID after being entered into the database. 
c. Plate scanning and scoring 
Random plates were regularly scanned by the Cryscam, a robotic image viewing 
device, according to the viewing schedule. The images of each droplet containing protein 
sample were taken and stored in a local network system within LBNL and were also 
updated every 24 hours to posted automatically in the TBSGC database with updates of 
every 24 hours. These images were scored through complementary software called 
Cryscore according to the scoring scale (Table 1) to find any initial crystal hits. Any 
droplets with score 6 or above were viewed under the Nikon microscope to confirm 
initial crystal hits.  
d. Optimization plates 
 With the confirmed initial crystal hit, eight optimization plates were setup for the 
Rc0731c based on 2 out of 12 initial crystal hit conditions. For optimization plates, the 
Greiner-plates were used instead with total 1.0 µL droplet size. A Greiner-plate is divided 
into four different quadrants with various buffer pH values and gradient concentrations of 
precipitants and salts for improving crystal quality.  Most improved crystals were from 
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optimization conditions of 0.1M Tris pH 8.0-8.5, 30% PEG 3350, and 15-30% 
isopropanol. 
Crystal harvesting and data collection 
The crystals with score 8 and 9 were harvested with cryo-protectants using 
Hampton loop under the high magnified microscope and frozen in the liquid nitrogen. 
Crystal samples were screened at both beamline in Advance Light Source (ALS) and 
Stanford Synchrotron Radiation Laboratory (SSRL) for X-ray diffraction. The Br soaking 
crystal has the cryo condition of 80% mother liquor + 20% glycerol + 1N NaBr soaking 
for 3 mins, and the native crystal has a cryo condition of mother liquor + 20% glycerol. 
The Br MAD data were collected under multiple wavelengths of peak, inflection and high 
remote energy (Figure 2). The data were good to 1.8Å (Figure 3a). The native crystal was 
diffracted initially to 1.0Å, and the dataset was good at 1.2Å of an atomic resolution. 
(Figure 3b).  The structure solution from Br MAD (Multiwavelengths anomalous 
diffraction) data provided an interpretable electron density map of a three dimensional 
protein model. 
 
Results and Discussions 
Rv0731c is a conserved hypothetical protein with unknown function. This protein 
is from Mycobacterium Tuberculosis which has 318 amino acids with molecular weight 
of about 35 kDalton. The protein sequence of Rv0731c is shown in the Table 2.         
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Crystallization process of Rv0731c was from 5x2 random plates with 448 unique 
crystallization conditions. There were total 12 random crystal hits were found from these 
random screen plates. The data of random crystal hits are listed in the Table 3. 
Based on 2 conditions of initial crystal hits, 8 optimization plates were setup for 
Rv0731c. Crystals with scores 8 or better from both random and optimization plates were 
harvested and screened through X-ray diffraction in the ALS beamline. This structure 
was determined quickly within 20 crystals being screened at synchrotron. The best 
diffraction was improved from 2.4 Å of initial crystal hits to 1.0 Å after crystal 
optimization. The X-ray diffracted resolution was improved nicely to an atomic 
resolution level. 
 The Br soaking crystal MAD data were collected at multi-wavelengths of peak, 
inflection and high remote energy. MAD data were processed well to 1.8Å. The native 
crystal dataset was good to an atomic resolution of 1.2 Å. The initial crystal structure was 
determined from Br soaking MAD data and native data which was good to extend the 
phasing to an atomic resolution of 1.2Å. The structure refinement is underway.  
The three dimensional protein structure of Rv0731c was determined with Br 
soaking MAD method. The initial crystal structure shows several β-strands are 
surrounded by multiple α-helixes (Figure 4). Rv0731c is a protein from Mycobacterium 
Tuberculosis with unknown function. The sequence homologous blast search did not give 
any convincing hits lower than e-3 value. Once the protein model building is more 
completed along with the ongoing structure refinement, more structure analysis will be 
done and hopefully it may help for protein function study.   
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Table 1. Scoring Scale 
 
 
 
 
 
 
 
 
 
 
 
0:  
clear 
drop 
1:  
unable to 
accurately record 
or salt crystal 
2: 
 light 
precipiate 
3: 
heavy 
precipitate 
4: 
phase 
separation 
5: 
organized 
precipitate 
6: 
crystal 
cluster 
7: 
microcrystal 
8: 
small single 
crystal 
(=<100um) 
9:  
large 
single crystal 
(>100um) 
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Table 2. Amino Acid Sequence of Rv0731c 
MTQTGSARFEGDSWDLASSVGLTATMVAAARAVAGRAPGALVND 
QFAEPLVRAVGVDFFVRMASGELDPDELAEDEANGLRRFADAMAI 
RTHYFDNFFLDATRAGIRQAVILASGLDSRAYRLRWPAGTIVFEVD 
QPQVIDFKTTTLAGLGAAPTTDRRTVAVDLRDDWPTALQKAGFDN 
AQRTAWIAEGLLGYLSAEAQDRLLDQITAQSVPGSQFATEVLRDIN 
RLNEEELRGRMRRLAERFRRHGLDLDMSGLVYFGDRTDARTYLAD 
HGWRTASASTTDLLAEHGLPPIDGDDAPFGEVIYVSAELKQKHQDTR 
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Table 3. Random Crystal Hits 
plate 
number well crystal type screen type screen tube crystallization condition 
600077 B10L single crystal  HP_I_II HP_I, #22 
0.1M Tris pH 8.5, 30% PEG 
4000, 0.2M NaAc 
600106 B2L 
needle 
clusters WZ_I_II_r2 WZ_I, #14 
0.1M cacodylate pH 6.5, 1M 
sodium citrate 
600106 B8L 
needle 
clusters WZ_I_II_r2 WZ_I, #20 
0.1M imidazole pH 8.0, 0.4M 
Na
 
H2PO4 , 1.6 M K H2PO4, 
0.2M NaCl 
600106 E4L 
needle 
clusters WZ_I_II_r2 WZ_II, #4 
0.1M cacodylate pH 6.5, 2.0M 
(NH4)3SO4, 0.2M NaCl 
600106 G7L 
needle 
clusters WZ_I_II_r2 WZ_II, #31 
0.1M Tris pH 7.0, 1M sodium 
citrate, 0.2M NaCl 
600108 A03L 
needle 
clusters  EM_64screen_r1 
EM_64screen, 
#3 
0.1M HEPES pH7.5, 2M 
(NH4)2SO4, 1% MPD 
600108 A4L 
needle 
clusters EM_64screen_r1 
EM_64screen, 
#4 
0.1M Tris pH 8.5, 5% PEG 
400, 2M (NH4)2SO4, 0.05M 
MgSO4,  
600108 A9L 
needle 
cluster EM_64screen_r1 
EM_64screen, 
#9 
0.1M Na/K phosphate pH 6.5, 
2% PEG 400  
600108 B6L needles EM_64screen_r1 
EM_64screen, 
#18 
0.1M Tris pH 8.5, 2% PEG 
400, 2M Li2SO4 
600108 B10L microcrystals EM_64screen_r1 
EM_64screen, 
#22 
0.1M imidazole pH 6.5, 30% 
isopropanol, 1.3M NaCl, 0.1M 
CaCl2 
600108 C12B plates EM_64screen_r1 
EM_64screen, 
#36 
0.1M Tris pH 8.5, 30% PEG 
3350, 30% isopropanol 
600108 D5L microcrystals EM_64screen_r1 
EM_64screen, 
#41 
0.1 M Tris pH 8.5, 25% PEG 
400, 20% PEG 3350, 0.1M 
MgCl2  
600109 C12L 
needle 
clusters Membfac_CSLite Membfac, #36 
 0.1M HEPES pH 7.5, 1M 
sodium citrate , 0.25M 
NaH2PO4 
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Figure 1. Crystallographic pipeline in this lab 
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Figure 2. Br Fluorescence Scan Diagram 
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Figure 3: Rv0731c Crystals and X-ray diffraction images 
 
  
      a) Br soaking crystal for data collection and corresponding diffractoin image 
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b) Rv0731c native crystal for data collection and corresponding diffractoin image 
 
 
Figure 4.  Initial Structure solution of Protein Rv0731c 
 
 
 
